Minims (Fluorescein Sodium)

Fluorescein Sodium, the active ingredient in Minims, is an ophthalmic diagnostic agent presented as an ophthalmic solution for ocular use. It stains the ocular surface to help visualize corneal defects and evaluate tear film integrity in patients undergoing eye examinations, and is commonly used by ophthalmologists and optometrists.

GNH USA supplies Minims as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with distribution across the European Union and other regulated markets, ensuring consistent quality and regulatory compliance.

Fluorescein Sodium is used in ophthalmology to assess the ocular surface and tear film. - Corneal abrasion: highlights epithelial defects for accurate diagnosis. - Tear film assessment: visualizes break‑up time to evaluate dry eye severity. - Ocular surface integrity: delineates staining patterns to monitor ocular surface disease.

Fluorescein sodium may cause ocular and systemic reactions, most of which are mild and transient.

Common Side Effects: - Transient ocular irritation or burning sensation. - Temporary yellow‑green staining of the tear film. - Mild conjunctival redness. - Slight visual disturbance under bright light.

Serious or Rare Side Effects: - Severe allergic reaction including angioedema. - Anaphylaxis requiring emergency treatment. - Corneal toxicity with prolonged exposure. - Systemic hypersensitivity manifesting as rash or urticaria.

When using Minims, consider the following precautions: - Allergy assessment: verify no known hypersensitivity to fluorescein or related dyes. - Pregnancy: use only if the potential benefit justifies the potential risk; safety data are limited. - Contact lens wearers: remove lenses before administration to avoid staining. - Concurrent ocular medications: avoid use with certain anesthetic drops that may mask discomfort. - Storage: Store at room temperature below 25°C: keep in original container, protect from light and moisture.

Fluorescein sodium can interact with other agents applied to the eye.

Major Interactions (Avoid): - Topical anesthetics containing proparacaine: may mask discomfort and delay detection of toxicity. - Systemic sulfonamide antibiotics: potential cross‑reactivity in sensitized individuals. - Other ocular dyes: concurrent use may cause additive staining and interfere with interpretation.

Moderate Interactions (Monitor Closely): - Eye lubricants: may dilute the dye, affecting visualization quality. - Contact lens solutions: can alter staining patterns and reduce diagnostic accuracy. - Systemic antihistamines: may reduce tear film stability, influencing test results.